October 17, 2017 3:12 AM ET

Biotechnology

Company Overview of 3-D Matrix, Inc.

Key Executives for 3-D Matrix, Inc.

NameBoard RelationshipsTitleAge
Keiji Nagano MBA22 RelationshipsChairman and Chief Executive Officer63
Alan Grodzinsky Ph.d.7 RelationshipsScientific Co-Founder and Member of Scientific Advisory Board--
Carlos Semino Ph.D.7 RelationshipsScientific Co-Founder and Member of Scientific Advisory Board--
Marc G. Rioult Ph.D., MBANo RelationshipsManaging Director--

3-D Matrix, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Keiji Nagano MBA 22 Relationships3-D Matrix, Inc.63
Alan Grodzinsky Ph.d. 7 Relationships3-D Matrix, Inc.--
Carlos Semino Ph.D. 7 Relationships3-D Matrix, Inc.--
Robert S. Langer Jr., Ph.D., Sc.D. 562 RelationshipsInVivo Therapeutics Holdings Corp.68
John W. Maki 43 RelationshipsVicus Therapeutics LLC54
View All Board Members

3-D Matrix, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Jr., Ph.D., Sc.D.Robert S. Langer562 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
387.5K
Bonus
240.4K
Total Short Term Compensation
482.5K
Total Value of Options
17.9M
Compensation as of Fiscal Year
3-D Matrix, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Silence Therapeutics plc Appoints Annalisa Jenkins as Non-Executive Chair of Board of Directors
October 16, 2017 6:00 AM ET
Ablynx, Inc. Appoints Daniel Schneider as General Manager
October 16, 2017 5:01 AM ET
Cellmid Limited Appoints Martin Cross as Non-Executive Director
October 15, 2017 9:47 PM ET
Navidea Biopharmaceuticals, Inc Announces Board Changes
October 13, 2017 8:01 PM ET
BioAegis Therapeutics, Inc. Hires Mark J. Dinubile as Chief Medical Officer
October 13, 2017 2:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact 3-D Matrix, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.